http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112691114-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2021-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112691114-B |
| titleOfInvention | Application of momordica polysaccharide in preparation of medicine for treating ulcerative colitis and pharmaceutical preparation of momordica polysaccharide |
| abstract | The invention discloses application of momordica polysaccharide in preparation of a medicine for treating ulcerative colitis and a medicinal preparation thereof, and belongs to the field of biological medicines. The ulcerative colitis is induced by dextran sodium sulfate. Experiments show that the momordica polysaccharide improves clinical symptoms by reducing disease activity indexes by recovering body weight and excrement viscosity and reducing bleeding; protecting inflammatory damaged intestinal tracts by repairing the mucosal barrier function of colon tissues; by attenuating the expression of inflammatory cytokines in the colon and reducing CD4 + T cell recruitment ameliorates immune system disturbances in ulcerative colitis. The invention widens the application field of the momordica polysaccharide, provides experimental basis for the clinical application of the momordica polysaccharide in the aspect of preparing the ulcerative colitis treatment medicine, and has good application prospect and huge potential value and social significance. |
| priorityDate | 2021-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.